Newsroom | 14417 results
Sorted by: Latest
-
Northwell’s Center for Gun Violence Prevention Awarded CDC Research Grant to Expand Firearm Safety Screening to Women’s Health Clinics
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Northwell Health’s Center for Gun Violence Prevention has developed a proven approach to firearm injury prevention, and now, with a $650,000, one-year research grant from the Centers for Disease Control and Prevention (CDC), the health system is expanding that work with a focused lens on women’s health. The grant will fund a new study integrating the health system’s universal firearm safety screening and education into routine women’s health care, bringing...
-
BetterUp Canada Inc. Debuts Groundbreaking Study for Ontario First Responders
TORONTO--(BUSINESS WIRE)--BetterUp Canada Inc., the Canadian operations of BetterUp®, the human transformation company and pioneer of virtual coaching, today announced The Ontario Frontline Study, a first-of-its-kind research program centred on first responders and healthcare workers. The research effort is a multi-year study that aims to explore whether and how personalized coaching can build resilience, reduce stress, and improve overall well-being for these workers, who operate in immensely...
-
Antibody Designed by Spanish Biopharma Oncomatryx Shows That Attacking the Tumor Environment Also Kills Cancer Cells
ZAMUDIO, Spain--(BUSINESS WIRE)--Oncomatryx, the Basque biopharmaceutical company pioneering the treatment of solid tumors through their microenvironment, has taken part, together with German research institutions, in a study showing in patient tumor tissue that destroying the cells that protect the tumor also kills cancer cells. This was achieved by OMTX305, a bispecific antibody designed by the company that directs the patient’s own T cells against the fibroblasts surrounding the tumor. The w...
-
Argonne to Advance Scientific Discovery With New Genesis Mission Awards
LEMONT, Ill.--(BUSINESS WIRE)--Argonne and collaborators will use super intelligence (SI) to speed discovery in software, materials, physics and more...
-
Resumen: Fuji Electric se une a Helical Fusion como inversor estratégico y socio oficial, mientras los fondos recaudados en el segundo cierre de una ronda de financiación serie B llegan a 3230 millones de yenes
TOKIO--(BUSINESS WIRE)--Helical Fusion Co., Ltd., una empresa de fusión de energía que está desarrollando un estelerador helicoidal con el objetivo de lograr energía de fusión comercialmente viable en la década de 2030, anunció hoy la finalización del segundo cierre de una ronda de financiación serie B por 3230 millones de yenes (aproximadamente 20,6 millones de dólares). La ronda representa otra expansión de la coalición industrial formada en torno al programa Helix de Helical Fusion. El comun...
-
Riassunto: Fuji Electric entra in Helical Fusion come investitore strategico e partner ufficiale mentre al secondo closing del round di finanziamento di serie ‘B’ sono stati raccolti 3,23 miliardi di JPY
TOKYO--(BUSINESS WIRE)--Helical Fusion Co., Ltd., azienda operante nel settore dell’energia da fusione e impegnata nello sviluppo di uno stellarator elicoidale con l’obiettivo di realizzare l’energia da fusione a livello commerciale entro la fine del 2030, oggi ha annunciato il completamento del secondo closing del round di finanziamento di serie ‘B’ per un totale di 3,23 miliardi di JPY (circa 20,6 milioni di USD). Il round segna un’ulteriore espansione della coalizione industriale che si sta...
-
Samenvatting: Fuji Electric sluit zich aan bij Helical Fusion als strategische investeerder en officiële partner; tweede ronde van Serie B-financiering levert 3,23 miljard JPY op
TOKIO--(BUSINESS WIRE)--Helical Fusion Co., Ltd., een fusie-energiebedrijf dat een Helical Stellarator ontwikkelt met als doel in de jaren 2030 commercieel haalbare fusie-energie te realiseren, heeft vandaag de afronding bekendgemaakt van een tweede ronde van de Serie B-financiering ter waarde van 3,23 miljard JPY (ongeveer 20,6 miljoen USD). Deze financieringsronde betekent een verdere uitbreiding van de industriële coalitie die zich rond het Helix-programma van Helical Fusion vormt. Deze beke...
-
Fuji Electric rejoint Helical Fusion en tant qu'investisseur stratégique et partenaire officiel, à l'occasion de la deuxième clôture de la série B à 3,23 milliards JPY
TOKYO--(BUSINESS WIRE)--Helical Fusion Co., Ltd., société spécialisée dans l'énergie de fusion qui développe un stellarator hélicoïdal avec l'objectif d'atteindre une énergie de fusion commercialement viable dans les années 2030, annonce aujourd'hui la clôture de la deuxième tranche de sa série B, pour un montant de 3,23 milliards JPY (environ 20,6 millions USD). Ce tour marque un nouvel élargissement de la coalition industrielle qui se forme autour du programme Helix de Helical Fusion. Fuji El...
-
Fuji Electric wird strategischer Investor und offizieller Partner von Helical Fusion – im Rahmen des zweiten Abschlusses der Serie-B-Finanzierungsrunde werden 3,23 Milliarden Yen eingeworben
TOKIO--(BUSINESS WIRE)--Helical Fusion Co., Ltd., ein Unternehmen im Bereich der Fusionsenergie, das einen Helical-Stellarator entwickelt, um in den 2030er Jahren kommerziell nutzbare Fusionsenergie zu erzielen, gab heute den Abschluss einer zweiten Finanzierungsrunde der Serie B in Höhe von 3,23 Milliarden JPY (ca. 20,6 Millionen USD) bekannt. Diese Finanzierungsrunde markiert eine weitere Erweiterung des Industrieverbunds, der sich um das „Helix-Programm“ von Helical Fusion bildet. Fuji Elect...
-
Philips Oral Healthcare Establishes Global Clinical Advisory Board to Help Shape the Future of Oral Care Through Scientific and Clinical Insight
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in oral healthcare, today announced the formation of the Philips Sonicare Global Clinical Advisory Board, a group of external oral healthcare experts established to help shape the future of Philips Oral Healthcare through science, clinical insight and meaningful innovation. The board brings together 12 international experts with complementary expertise across clinical practice, research, education, behavior change...